Name:
Adduct:
Polarity:
Z:
m/z:
±:
CCS: Å2
±: %
SMI:
Type:

Make a CSV file containing information about your queries.
Then upload the CSV file below and click on "Make Queries" to view the results online
and click "Download Results" to download the entire results in one excel file.
An example of the CSV file can be found below

Download Example CSV


**Make sure the header column names are as follows**

...



Upload a CSV file

1
May, J. C. et al. Conformational Ordering of Biomolecules in the Gas Phase: Nitrogen Collision Cross Sections Measured on a Prototype High Resolution Drift Tube Ion Mobility-Mass Spectrometer. Anal. Chem. 86, 2107–2116 (2014).


2
Paglia, G. et al. Ion Mobility Derived Collision Cross Sections to Support Metabolomics Applications. Anal. Chem. 86, 3985–3993 (2014).


3
Groessl, M., Graf, S. & Knochenmuss, R. High resolution ion mobility-mass spectrometry for separation and identification of isomeric lipids. Analyst 140, 6904–6911 (2015).


4
Zhou, Z., Shen, X., Tu, J. & Zhu, Z.-J. Large-Scale Prediction of Collision Cross-Section Values for Metabolites in Ion Mobility-Mass Spectrometry. Anal. Chem. 88, 11084–11091 (2016).


5
Hines, K. M., Herron, J. & Xu, L. Assessment of altered lipid homeostasis by HILIC-ion mobility-mass spectrometry-based lipidomics. The Journal of Lipid Research 58, 809–819 (2017).


6
Bijlsma, L. et al. Prediction of Collision Cross-Section Values for Small Molecules: Application to Pesticide Residue Analysis. Anal. Chem. 89, 6583–6589 (2017).


7
Hines, K. M., Ross, D. H., Davidson, K. L., Bush, M. F. & Xu, L. Large-Scale Structural Characterization of Drug and Drug-Like Compounds by High-Throughput Ion Mobility-Mass Spectrometry. Anal. Chem. 89, 9023–9030 (2017).


8
Stow, S. M. et al. An Interlaboratory Evaluation of Drift Tube Ion Mobility–Mass Spectrometry Collision Cross Section Measurements. Anal. Chem. 89, 9048–9055 (2017).


9
Zhou, Z., Tu, J., Xiong, X., Shen, X. & Zhu, Z.-J. LipidCCS: Prediction of Collision Cross-Section Values for Lipids with High Precision To Support Ion Mobility–Mass Spectrometry-Based Lipidomics. Anal. Chem. 89, 9559–9566 (2017).


10
Zheng, X. et al. A structural examination and collision cross section database for over 500 metabolites and xenobiotics using drift tube ion mobility spectrometry. Chem. Sci. 8, 7724–7736 (2017).


11
Hines, K. M. et al. Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics. mSphere 2, 99–16 (2017).


12
Lian, R. et al. Ion mobility derived collision cross section as an additional measure to support the rapid analysis of abused drugs and toxic compounds using electrospray ion mobility time-of-flight mass spectrometry. Anal. Methods 10, 749–756 (2018).


13
Mollerup, C. B., Mardal, M., Dalsgaard, P. W., Linnet, K. & Barron, L. P. Prediction of collision cross section and retention time for broad scope screening in gradient reversed-phase liquid chromatography-ion mobility-high resolution accurate mass spectrometry. Journal of Chromatography A 1542, 82–88 (2018).


14
Righetti, L. et al. Ion mobility-derived collision cross section database: Application to mycotoxin analysis. Analytica Chimica Acta 1014, 50–57 (2018).


15
Tejada-Casado, C. et al. Collision cross section (CCS) as a complementary parameter to characterize human and veterinary drugs. Analytica Chimica Acta 1043, 52–63 (2018).


16
Nichols, C. M. et al. Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass Spectrometry. Anal. Chem. 90, 14484–14492 (2018).


17
Hines, K. M. & Xu, L. Lipidomic consequences of phospholipid synthesis defects in Escherichia coli revealed by HILIC-ion mobility-mass spectrometry. Chemistry and Physics of Lipids 219, 15–22 (2019).


18
Leaptrot, K. L., May, J. C., Dodds, J. N. & McLean, J. A. Ion mobility conformational lipid atlas for high confidence lipidomics. Nature Communications 1–9 (2019).


19
Blaženović, I. et al. Increasing Compound Identification Rates in Untargeted Lipidomics Research with Liquid Chromatography Drift Time–Ion Mobility Mass Spectrometry. Anal. Chem. 90, 10758–10764 (2018).


20
Vasilopoulou, C. G. et al. Trapped ion mobility spectrometry and PASEF enable in-depth lipidomics from minimal sample amounts. Nature Communications 1–11 (2020).


21
Tsugawa, H. et al. MS-DIAL 4: accelerating lipidomics using an MS/MS, CCS, and retention time atlas. bioRxiv 37, 513 (2020).


22
Poland, J. C. et al. Collision Cross Section Conformational Analyses of Bile Acids via Ion Mobility–Mass Spectrometry. Journal of the American Society for Mass Spectrometry 31, 1625–1631 (2020).


23
Dodds, J. et al. Rapid Characterization of Per- and Polyfluoroalkyl Substances (PFAS) by Ion Mobility Spectrometry−Mass Spectrometry (IMS-MS). Anal. Chem. 92, 4427-4435 (2020).


24
Celma, A. et al. Improving Target and Suspect Screening High-Resolution Mass Spectrometry Workflows in Environmental Analysis by Ion Mobility Separation. Environ. Sci. Technol. 54, 15120-15131 (2020)


25
Belova, L. et al. Ion Mobility-High-Resolution Mass Spectrometry (IM-HRMS) for the Analysis of Contaminants of Emerging Concern (CECs): Database Compilation and Application to Urine Samples. Anal. Chem. XXX, XXXX-XXXX (2021)


26
Ross, D. H., et al. High-Throughput Measurement and Machine Learning-Based Prediction of Collision Cross Sections for Drugs and Drug Metabolites. J Am Soc Mass Spectr 33, 1061–1072 (2022).


ID Name Adduct Structure m/z CCS SMI Type Z Ref CCS Type CCS method
CCSBASE_C302D9B19E 12a-HYDROXY-5-DEOXYDEHYDROMUNDUSERONE [M+H-H2O]+ 325.1075 173.0 COC1=CC2=C(C=C1)C=C3C4=CC(=C(C=C4OCC3(O2)O)OC)OC small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_CB07F751BD LATHOSTEROL [M+H-H2O]+ 369.3521 204.0 C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_D3697A2C2C METAMECONINE [M+H]+ 195.0652 137.6 COC1=C(C=C2C(=C1)COC2=O)OC small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_94CB2696F9 3-ACETYLCOUMARIN [M+H]+ 189.0546 131.6 CC(=O)C1=CC2=CC=CC=C2OC1=O small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_431AAA67D3 8-CYCLOPENTYLTHEOPHYLLINE [M+H]+ 249.1346 158.6 CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3CCCC3 small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_63F91407DA TETRAHYDROGAMBOGIC ACID [M+H]+ 633.3422 246.4 CC(=CCCC1(C=CC2=C(O1)C(=C3C(=C2O)C(=O)C4CC5CC6C4(O3)C(C5O)(OC6(C)C)C/C=C(/C)\C(=O)O)CC=C(C)C)C)C small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_1685643D49 AMINOBENZTROPINE [M+H]+ 323.2118 180.6 CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4N small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_244C72FD9F 6-HYDROXYTROPINONE [M+H]+ 156.1019 131.6 CN1[C@@H]2CC([C@H]1CC(=O)C2)O small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_C49C8C251C beta-CARYOPHYLLENE ALCOHOL [M+H]+ 223.2057 146.1 CC1(CC2C1CCC3(CCCC2(C3)O)C)C small molecule 1 7 TW calibrated with polyalanine and drug standards
CCSBASE_A6D5AC508E DEACETOXY(7)-7-OXOKHIVORINIC ACID [M+H]+ 521.2381 212.6 CC(=O)O[C@H]1C[C@H](C(C2[C@]1(C3CC[C@]4([C@@H](OC(=O)C5C4([C@@]3(C(=O)C2)C)O5)C(=O)O)C)C)(C)C)OC(=O)C small molecule 1 7 TW calibrated with polyalanine and drug standards
1 2 ... 203 204 205 206 207 208 209 ... 1698 1699